Charles Schwab’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Buy |
246,086
+12,525
| +5% | +$125K | ﹤0.01% | 2606 |
|
|
2025
Q1 | $1.39M | Buy |
233,561
+34,365
| +17% | +$205K | ﹤0.01% | 2732 |
|
|
2024
Q4 | $1.53M | Sell |
199,196
-22,939
| -10% | -$176K | ﹤0.01% | 2757 |
|
|
2024
Q3 | $2.27M | Buy |
222,135
+8,397
| +4% | +$85.7K | ﹤0.01% | 2666 |
|
|
2024
Q2 | $3.17M | Buy |
213,738
+7,873
| +4% | +$117K | ﹤0.01% | 2539 |
|
|
2024
Q1 | $2.81M | Buy |
205,865
+4,315
| +2% | +$58.9K | ﹤0.01% | 2493 |
|
|
2023
Q4 | $2.21M | Sell |
201,550
-8,621
| -4% | -$94.4K | ﹤0.01% | 2585 |
|
|
2023
Q3 | $2.3M | Buy |
210,171
+19,258
| +10% | +$211K | ﹤0.01% | 2555 |
|
|
2023
Q2 | $2.53M | Buy |
190,913
+7,947
| +4% | +$105K | ﹤0.01% | 2480 |
|
|
2023
Q1 | $2.49M | Buy |
182,966
+477
| +0.3% | +$6.49K | ﹤0.01% | 2464 |
|
|
2022
Q4 | $3.56M | Buy |
182,489
+4,322
| +2% | +$84.4K | ﹤0.01% | 2377 |
|
|
2022
Q3 | $3.39M | Buy |
178,167
+27,288
| +18% | +$520K | ﹤0.01% | 2417 |
|
|
2022
Q2 | $3.11M | Buy |
150,879
+5,130
| +4% | +$106K | ﹤0.01% | 2396 |
|
|
2022
Q1 | $4.69M | Buy |
145,749
+3,174
| +2% | +$102K | ﹤0.01% | 2308 |
|
|
2021
Q4 | $6.64M | Buy |
142,575
+2,057
| +1% | +$95.8K | ﹤0.01% | 2210 |
|
|
2021
Q3 | $3.79M | Buy |
140,518
+43,432
| +45% | +$1.17M | ﹤0.01% | 2499 |
|
|
2021
Q2 | $2.49M | Buy |
97,086
+3,374
| +4% | +$86.6K | ﹤0.01% | 2633 |
|
|
2021
Q1 | $3.2M | Buy |
93,712
+18,961
| +25% | +$648K | ﹤0.01% | 2509 |
|
|
2020
Q4 | $2.53M | Buy |
74,751
+5,610
| +8% | +$190K | ﹤0.01% | 2530 |
|
|
2020
Q3 | $1.71M | Buy |
+69,141
| New | +$1.71M | ﹤0.01% | 2544 |
|